Skip to main content

Opioid Crisis: First State Court Trial To Begin in May 2019

Opioid Crisis: First State Court Trial To Begin in May 2019

Opioid Crisis: First State Court Trial To Begin in May 2019

Introduction

Cleveland County District Judge Thad Balkman set May 28, 2019, as the date for initiating the trial for the opioid litigation against the Opioid Big Pharma industry and its affiliates in Oklahoma.

The lawsuits filed in June 2017 by various states blamed opioid manufacturers Purdue Pharma, Allergan, Janssen Pharmaceuticals, Teva Pharmaceuticals and several others for false marketing tactics which led to the opioid epidemic. Other than Oklahoma, several states like Ohio, Alaska, Kentucky, Louisiana, Mississippi, Missouri, Montana, New Hampshire, New Jersey, New Mexico, South Carolina, and Washington have filed lawsuits previously. The distributors played an integral role in opioid overdose deaths by not keeping track of oversupply, and failure to identify suspicious orders and report them to authorities. Attorney General Mike Hunter assured that Judge Balkman's move will help resolve the plight of many opioid victims throughout the nation.

Opioid overdoses corresponded to 66% of all drug overdose deaths in 2016. More than 400 opioid-related lawsuits are centralized as a part of multidistrict litigation, MDL No 2804 (In Re: National Prescription Opiate Litigation) in the Northern District of Ohio before U.S. District Judge Dan A. Polster. Recently, attorneys undertaking opioid litigation for babies born with birth defects due to opioid use by their mothers, requested a separate legal track within the MDL to address their medical expense concerns before Judge Polster.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!